| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 74307* | 2014 |
| Liraglutide and cardiovascular outcomes in type 2 diabetes SP Marso, GH Daniels, K Brown-Frandsen, P Kristensen, JFE Mann, ... New England Journal of Medicine 375 (4), 311-322, 2016 | 7338 | 2016 |
| Semaglutide and cardiovascular outcomes in patients with type 2 diabetes SP Marso, SC Bain, A Consoli, FG Eliaschewitz, E Jódar, LA Leiter, ... New England Journal of Medicine 375 (19), 1834-1844, 2016 | 5662 | 2016 |
| A prospective natural-history study of coronary atherosclerosis GW Stone, A Maehara, AJ Lansky, B De Bruyne, E Cristea, GS Mintz, ... New England journal of medicine 364 (3), 226-235, 2011 | 3586 | 2011 |
| Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ... New England Journal of Medicine 377 (13), 1228-1239, 2017 | 2066 | 2017 |
| Liraglutide and renal outcomes in type 2 diabetes JFE Mann, DD Ørsted, K Brown-Frandsen, SP Marso, NR Poulter, ... New England Journal of Medicine 377 (9), 839-848, 2017 | 1246 | 2017 |
| Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year … JA Suero, SP Marso, PG Jones, SB Laster, KC Huber, LV Giorgi, ... Journal of the American College of Cardiology 38 (2), 409-414, 2001 | 895 | 2001 |
| Peripheral arterial disease in patients with diabetes SP Marso, WR Hiatt Journal of the American College of Cardiology 47 (5), 921-929, 2006 | 740 | 2006 |
| Efficacy and safety of degludec versus glargine in type 2 diabetes SP Marso, DK McGuire, B Zinman, NR Poulter, SS Emerson, TR Pieber, ... New England Journal of Medicine 377 (8), 723-732, 2017 | 705 | 2017 |
| Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials H Abuissa, PG Jones, SP Marso, JH O’Keefe Journal of the American College of Cardiology 46 (5), 821-826, 2005 | 672 | 2005 |
| Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus DL Bhatt, SP Marso, AT Hirsch, PA Ringleb, W Hacke, EJ Topol American Journal of Cardiology 90 (6), 625-628, 2002 | 584 | 2002 |
| Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk M Kosiborod, SE Inzucchi, HM Krumholz, L Xiao, PG Jones, S Fiske, ... Circulation 117 (8), 1018-1027, 2008 | 538 | 2008 |
| Abciximab reduces mortality in diabetics following percutaneous coronary intervention DL Bhatt, SP Marso, AM Lincoff, KE Wolski, SG Ellis, EJ Topol Journal of the American College of Cardiology 35 (4), 922-928, 2000 | 445 | 2000 |
| Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial … SP Marso, AM Lincoff, SG Ellis, DL Bhatt, JF Tanguay, NS Kleiman, ... Circulation 100 (25), 2477-2484, 1999 | 444 | 1999 |
| Central role of RAGE-dependent neointimal expansion in arterial restenosis T Sakaguchi, SF Yan, S Du Yan, D Belov, LL Rong, M Sousa, M Andrassy, ... The Journal of clinical investigation 111 (7), 959-972, 2003 | 414 | 2003 |
| Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease FD Porter, DE Scherrer, MH Lanier, SJ Langmade, V Molugu, SE Gale, ... Science translational medicine 2 (56), 56ra81-56ra81, 2010 | 400 | 2010 |
| Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative MB Basir, NK Kapur, K Patel, MA Salam, T Schreiber, A Kaki, I Hanson, ... Catheterization and Cardiovascular Interventions 93 (7), 1173-1183, 2019 | 378 | 2019 |
| Chronic total occlusion angioplasty in the United States JA Grantham, SP Marso, J Spertus, J House, DR Holmes, BD Rutherford JACC: Cardiovascular Interventions 2 (6), 479-486, 2009 | 360 | 2009 |
| Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention SP Marso, AP Amin, JA House, KF Kennedy, JA Spertus, SV Rao, ... Jama 303 (21), 2156-2164, 2010 | 336 | 2010 |
| Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry SK Mehta, AD Frutkin, JB Lindsey, JA House, JA Spertus, SV Rao, FS Ou, ... Circulation: Cardiovascular Interventions 2 (3), 222-229, 2009 | 333 | 2009 |
